Aristotle University Of Thessaloniki (AUTH)
Mechanisms of dopaminergic synaptic dysfunction in a mouse model of spinal muscular atrophy
Abstract
dc:descriptionThe development and maintenance of posture are among the earliest behaviors required for above ground locomotion in mammals. Neuromodulatory descending pathways and spinal motor circuits are complex yet essential for influencing intra-limb coordination and maintaining postural stability during locomotion. Assessing the neuromodulatory effects on rhythmic activity and motor behavior in mice has been crucial for understanding spinal locomotor network organization and the consequences of circuit dysfunction, yet the underlying mechanisms remain elusive. Dopamine and norepinephrine are two catecholamine’s essential for the initiation and coordination during movement. Reduction of dopamine and norepinephrine initiates the development of motor impairments linked to neurodegenerative disease. However, despite the use of in vivo and in vitro pharmacological treatments (Andersen et al., 2017; Kelly et al., 2009), neurotoxin induced lesions in areas of the brain (Kasanga et al., 2024; Wu et al., 2024), and optogenetic studies (Koblinger et al., 2018), the cellular and circuit mechanisms underlying the effects of catecholaminergic perturbations during early development and under pathological conditions are not well understood. Spinal muscular atrophy (SMA) is a neurodegenerative disease resulting from ubiquitous SMN (Survival of Motor Neuron) deficiency during early development, leading to severe motor dysfunction and postural deficits. In my PhD study, I investigated the role of catecholaminergic neuromodulation in a mouse model of SMA. By utilizing a combination of mouse genetics, behavioral assays, functional and anatomical approaches, we identified a progressive loss of catecholaminergic synapses from spinal neurons that occur via catecholaminergic-autonomous mechanisms. Importantly, we demonstrated that selective restoration of SMN in either catecholaminergic or serotonergic neurons is sufficient to correct key characteristics of the impaired locomotor activity in a SMA mouse model. In striking, contrast however, only a combined restoration of SMN in both catecholaminergic and serotonergic neurons, or pharmacological treatment with L-Dopa, improved significantly the severe postural deficits. These findings highlight novel synaptic and cellular mechanisms linked to deficits in catecholaminergic neuromodulation in SMA. The results from this thesis emphasize the importance of the combined effects of catecholaminergic and serotonergic systems on spinal locomotor networks, which influence the postural stability. Importantly, this thesis reveals that genetic restoration of SMN in catecholaminergic neurons or daily treatment with L-Dopa in vivo as promising therapeutic approach to alleviate the locomotor and postural deficits observed in SMA patients.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pagiazitis, John
- Παγιαζήτης, Ιωάννης
Subjects
dc:subject × 25- Νωτιαία μυϊκή ατροφία
- Ντοπαμίνη
- Νορεπινεφρίνη
- Κινητικός Νευρώνας
- Συντακτική δυσλειτουργία
- Κινητικές Δυσλειτουργίες
- Στατική Ασταθής
- Σύναψη νευρώνων
- L-DOPA
- Νευροεκφυλιστική ασθένεια
- Spinal muscular atrophy
- Dopamine
- Noradrenaline
- Motor neurons
- Synaptic Dysfunction
- Locomotion
- Posture
- Synapses
- Neurodegenerative diseases
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, γενικά
- Health Sciences
- Medical and Health Sciences
- Health sciences, general
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58353